Mirum Pharmaceuticals Financial Overview
Mirum Pharmaceuticals's market cap is currently $3.38B. The company's EPS TTM is $0.05; its P/E ratio is ―; Mirum Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
